Integro Theranostics
Clinical trials sponsored by Integro Theranostics, explained in plain language.
-
Glowing dye could help surgeons spot lung cancer
Diagnosis OngoingThis early-stage study is testing a new fluorescent dye called LS301-IT. The dye is given by IV before surgery and is designed to make lung cancer tissue glow under special light, helping surgeons see it more clearly. The main goal is to check if the dye is safe and to see how we…
Phase: PHASE1 • Sponsor: Integro Theranostics • Aim: Diagnosis
Last updated Apr 01, 2026 23:26 UTC
-
Glowing dye lights up cancer cells during surgery
Diagnosis OngoingThis study is testing a new fluorescent dye called LS301-IT. It is given by IV before surgery to help surgeons see the edges of breast cancer tissue and nearby lymph nodes more clearly. The main goals are to check if the dye is safe and to see how well it helps guide surgery for …
Phase: PHASE1, PHASE2 • Sponsor: Integro Theranostics • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC